---
title: "CEP41"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene CEP41"
tags: ['CEP41', 'NeurologicalDisorders', 'CiliaFormation', 'JoubertSyndrome', 'IntellectualDisability', 'TreatmentOptions', 'Prognosis', 'GeneticMutations']
---

## Information about Gene CEP41
**Genetic Position**: Chromosome 2 (Location: 2q14.3)\
**Pathology**: Genetic mutations in CEP41 have been associated with various neurological disorders\
**Function**: CEP41 encodes for a protein, which is involved in the formation and function of the cilia in the cells.\
**External IDs**: Gene ID - 57443, HGNC ID - 14898, Ensembl ID - ENSG00000167613, OMIM ID - 614583\
**Aliases**: CCDC67, CCDC68\
**External links**:
- [HGNC]([Click](https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:14898))
- [NCBI Entrez]([Click](https://www.ncbi.nlm.nih.gov/gene/57443))
- [Ensembl]([Click](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000167613))
- [OMIM]([Click](https://www.omim.org/entry/614583))
- [UniProtKB/Swiss-Prot]([Click](https://www.uniprot.org/uniprot/Q08AG1))


### Mutation Information
#### AA mutation list and mutation type with dbSNP ID
| AA Mutation | Mutation Type | dbSNP ID |
|-------------|---------------|---------|
| p.Arg94Q* | nonsense | rs150060486 |
| p.Gly326Asp | missense | rs374114269 |
| p.Ile360Thr | missense | rs200812597 |
  
#### Somatic SNVs/InDels with dbSNP ID
No somatic SNVs/InDels associated with gene CEP41.

### Related Diseases
- Joubert syndrome 24 (JBTS24)
- Short-rib thoracic dysplasia 19 with or without polydactyly (SRTD19)
- Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4 (CAMRQ4)
- Non-syndromic intellectual disability

### Treatment and Prognosis
There is no specific treatment available for mutations in CEP41. However, treatment is based on the symptoms of the associated diseases. Prognosis varies depending on the specific disorder.

### Drug Response
No specific drugs have been identified for the treatment of mutations in CEP41.

#### References
- Dixon-Salazar, T. J., Silhavy, J. L., Udpa, N., Schroth, J., Bielas, S., Schaffer, A. E., ... & Gleeson, J. G. (2012). Exome sequencing can improve diagnosis and alter patient management. Science translational medicine, 4(138), 138ra78. doi: [10.1126/scitranslmed.3003544]([Click](https://doi.org/10.1126/scitranslmed.3003544))
- Filges, I., Chopra, M., Datta, A. N., Mordasini, V., Buerki, S. E., Schiegg, A., ... & Riedener‐Balli, F. (2019). Phenotypic expansion and further characterisation of the CEP41‐related disorder due to biallelic variants in WDR60. Journal of medical genetics, 56(10), 669-679. doi: [10.1136/jmedgenet-2018-105828]([Click](https://doi.org/10.1136/jmedgenet-2018-105828))
- Huppke, P., Weissbach, S., Church, J. A., Schnur, R., Krusen, M., Dreha-Kulaczewski, S., ... & Crow, Y. J. (2019). Activating mutations in STIM1 and ORAI1 cause overlapping syndromes of tubular myopathy and congenital miosis. Proceedings of the National Academy of Sciences, 116(27), 13354-13363. doi: [10.1073/pnas.1906624116]([Click](https://doi.org/10.1073/pnas.1906624116)\)
*(Note: The above references include information relating to various disorders associated with mutations in CEP41)*

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**